AI-generated summary
The authors treated localized atopic dermatitis lesions in 12 adults and 6 children with 308 nm monochromatic excimer light in a pilot study. They report complete remission in 66.7% of patients, and 44% kept their results at 16-week follow-up. The authors describe the treatment as well tolerated.
- Participants
- 18
- Who or what was studied
- Twelve adults and six children with localized atopic dermatitis lesions
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract describes a pilot study with a small sample and does not mention a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 308 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dose, Pilot study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.